The Pathophysiology and Treatment of Pyoderma Gangrenosum—Current Options and New Perspectives
Open Access
- 19 February 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (4) , 2440
Abstract
Pyoderma gangrenosum (PG) is an uncommon inflammatory dermatological disorder characterized by painful ulcers that quickly spread peripherally. The pathophysiology of PG is not fully understood; however, it is most commonly considered a disease in the spectrum of neutrophilic dermatoses. The treatment of PG remains challenging due to the lack of generally accepted therapeutic guidelines. Existing therapeutic methods focus on limiting inflammation through the use of immunosuppressive and immunomodulatory therapies. Recently, several reports have indicated the successful use of biologic drugs and small molecules administered for coexisting diseases, resulting in ulcer healing. In this review, we summarize the discoveries regarding the pathophysiology of PG and present treatment options to raise awareness and improve the management of this rare entity.Keywords
Funding Information
- Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu (SUBK.C260.23.040)
This publication has 175 references indexed in Scilit:
- Extracutaneous involvement of pyoderma gangrenosumArchives of Dermatological Research, 2019
- Diagnostic Criteria of Ulcerative Pyoderma GangrenosumJAMA Dermatology, 2018
- Dapsone in dermatology and beyondArchives of Dermatological Research, 2013
- Interleukin 23 Expression in Pyoderma Gangrenosum and Targeted Therapy With UstekinumabArchives of Dermatology, 2011
- A clinical perspective of IL‐1β as the gatekeeper of inflammationEuropean Journal of Immunology, 2011
- Mycophenolate Mofetil as Therapy for Pyoderma GangrenosumArchives of Dermatology, 2009
- Successful treatment of pyoderma gangrenosum that developed in a patient with myelodysplastic syndromeJournal of Infection and Chemotherapy, 2003
- Self-reactive T cells and Degeneracy of T Cell Recognition: Evolving Concepts—from Sequence Homology to Shape Mimicry and TCR FlexibilityJournal of Autoimmunity, 2001
- Clinical Features and Treatment of Peristomal Pyoderma GangrenosumJAMA, 2000
- Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signallingSeminars in Immunology, 2000